305 related articles for article (PubMed ID: 21237267)
21. Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems.
Gordon S; Young K; Wilson R; Rizwan S; Kemp R; Rades T; Hook S
J Liposome Res; 2012 Sep; 22(3):193-204. PubMed ID: 22188610
[TBL] [Abstract][Full Text] [Related]
22. Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses.
Rizwan SB; McBurney WT; Young K; Hanley T; Boyd BJ; Rades T; Hook S
J Control Release; 2013 Jan; 165(1):16-21. PubMed ID: 23142776
[TBL] [Abstract][Full Text] [Related]
23. Controlling nanostructure and lattice parameter of the inverse bicontinuous cubic phases in functionalised phytantriol dispersions.
Fraser SJ; Mulet X; Hawley A; Separovic F; Polyzos A
J Colloid Interface Sci; 2013 Oct; 408():117-24. PubMed ID: 23928485
[TBL] [Abstract][Full Text] [Related]
24. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media.
Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
J Pharm Pharmacol; 2010 Jul; 62(7):844-55. PubMed ID: 20636872
[TBL] [Abstract][Full Text] [Related]
25. The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle.
Sherif S; Bendas ER; Badawy S
Eur J Pharm Biopharm; 2014 Feb; 86(2):251-9. PubMed ID: 24056055
[TBL] [Abstract][Full Text] [Related]
26. Lipid-PEG conjugates sterically stabilize and reduce the toxicity of phytantriol-based lyotropic liquid crystalline nanoparticles.
Zhai J; Hinton TM; Waddington LJ; Fong C; Tran N; Mulet X; Drummond CJ; Muir BW
Langmuir; 2015 Oct; 31(39):10871-80. PubMed ID: 26362479
[TBL] [Abstract][Full Text] [Related]
27. Transfer of lipid and phase reorganisation in self-assembled liquid crystal nanostructured particles based on phytantriol.
Tilley A; Dong YD; Amenitsch H; Rappolt M; Boyd BJ
Phys Chem Chem Phys; 2011 Feb; 13(8):3026-32. PubMed ID: 21240427
[TBL] [Abstract][Full Text] [Related]
28. Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz.
Avachat AM; Parpani SS
Colloids Surf B Biointerfaces; 2015 Feb; 126():87-97. PubMed ID: 25543986
[TBL] [Abstract][Full Text] [Related]
29. Silica nanoparticle stabilization of liquid crystalline lipid dispersions: impact on enzymatic digestion and drug solubilization.
Bhatt AB; Barnes TJ; Prestidge CA
Curr Drug Deliv; 2015; 12(1):47-55. PubMed ID: 25176029
[TBL] [Abstract][Full Text] [Related]
30. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive and comparative studies on nanocytotoxicity of glyceryl monooleate- and phytantriol-based lipid liquid crystalline nanoparticles.
Jagielski J; Przysiecka Ł; Flak D; Diak M; Pietralik-Molińska Z; Kozak M; Jurga S; Nowaczyk G
J Nanobiotechnology; 2021 Jun; 19(1):168. PubMed ID: 34082768
[TBL] [Abstract][Full Text] [Related]
32. Nanostructured Cubosomes in a Thermoresponsive Depot System: An Alternative Approach for the Controlled Delivery of Docetaxel.
Rarokar NR; Saoji SD; Raut NA; Taksande JB; Khedekar PB; Dave VS
AAPS PharmSciTech; 2016 Apr; 17(2):436-45. PubMed ID: 26208439
[TBL] [Abstract][Full Text] [Related]
33. Evaluating the link between self-assembled mesophase structure and drug release.
Phan S; Fong WK; Kirby N; Hanley T; Boyd BJ
Int J Pharm; 2011 Dec; 421(1):176-82. PubMed ID: 21963475
[TBL] [Abstract][Full Text] [Related]
34. PEGylation of phytantriol-based lyotropic liquid crystalline particles--the effect of lipid composition, PEG chain length, and temperature on the internal nanostructure.
Nilsson C; Østergaard J; Larsen SW; Larsen C; Urtti A; Yaghmur A
Langmuir; 2014 Jun; 30(22):6398-407. PubMed ID: 24833115
[TBL] [Abstract][Full Text] [Related]
35. Protein-bearing cubosomes prepared by liquid precursor dilution: inner ear delivery and pharmacokinetic study following intratympanic administration.
Liu H; Wang Y; Wang Q; Li Z; Zhou Y; Zhang Y; Li S
J Biomed Nanotechnol; 2013 Oct; 9(10):1784-93. PubMed ID: 24015508
[TBL] [Abstract][Full Text] [Related]
36. Phytantriol based smart nano-carriers for drug delivery applications.
Akbar S; Anwar A; Ayish A; Elliott JM; Squires AM
Eur J Pharm Sci; 2017 Apr; 101():31-42. PubMed ID: 28137471
[TBL] [Abstract][Full Text] [Related]
37. Preparation and Characterization of SN-38-Encapsulated Phytantriol Cubosomes Containing α-Monoglyceride Additives.
Ali MA; Noguchi S; Iwao Y; Oka T; Itai S
Chem Pharm Bull (Tokyo); 2016; 64(6):577-84. PubMed ID: 27250792
[TBL] [Abstract][Full Text] [Related]
38. Modulatory effect of human plasma on the internal nanostructure and size characteristics of liquid-crystalline nanocarriers.
Azmi ID; Wu L; Wibroe PP; Nilsson C; Østergaard J; Stürup S; Gammelgaard B; Urtti A; Moghimi SM; Yaghmur A
Langmuir; 2015 May; 31(18):5042-9. PubMed ID: 25884233
[TBL] [Abstract][Full Text] [Related]
39. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery.
Gordon S; Saupe A; McBurney W; Rades T; Hook S
J Pharm Pharmacol; 2008 Dec; 60(12):1591-600. PubMed ID: 19000363
[TBL] [Abstract][Full Text] [Related]
40. Understanding the interfacial properties of nanostructured liquid crystalline materials for surface-specific delivery applications.
Dong YD; Larson I; Barnes TJ; Prestidge CA; Allen S; Chen X; Roberts CJ; Boyd BJ
Langmuir; 2012 Sep; 28(37):13485-95. PubMed ID: 22889049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
